BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33728228)

  • 1. Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants.
    Zimerman RA; Cadegiani FA; Pereira E Costa RA; Goren A; Campello de Souza B
    Cureus; 2021 Mar; 13(3):e13819. PubMed ID: 33728228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
    Trobajo-Sanmartín C; Miqueleiz A; Portillo ME; Fernández-Huerta M; Navascués A; Sola Sara P; López Moreno P; Ordoñez GR; Castilla J; Ezpeleta C
    J Clin Microbiol; 2021 Nov; 59(12):e0173621. PubMed ID: 34495709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.
    Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H
    Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
    Hirotsu Y; Omata M
    PLoS Pathog; 2021 Jun; 17(6):e1009619. PubMed ID: 34097716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil.
    Lamarca AP; de Almeida LGP; Francisco RDS; Lima LFA; Scortecci KC; Perez VP; Brustolini OJ; Sousa ESS; Secco DA; Santos AMG; Albuquerque GR; Mariano APM; Maciel BM; Gerber AL; Guimarães APC; Nascimento PR; Neto FPF; Gadelha SR; Porto LC; Campana EH; Jeronimo SMB; Vasconcelos ATR
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009835. PubMed ID: 34644287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.
    Resende PC; Gräf T; Paixão ACD; Appolinario L; Lopes RS; Mendonça ACDF; da Rocha ASB; Motta FC; Neto LGL; Khouri R; de Oliveira CI; Santos-Muccillo P; Bezerra JF; Teixeira DLF; Riediger I; Debur MDC; Ribeiro-Rodrigues R; Leite AB; do Santos CA; Gregianini TS; Fernandes SB; Bernardes AFL; Cavalcanti AC; Miyajima F; Sachhi C; Mattos T; da Costa CF; Delatorre E; Wallau GL; Naveca FG; Bello G; Siqueira MM
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33919314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Protein S Variant in Patients Diagnosed with COVID-19.
    Bayirli-Turan D; Usanmaz M; Gorgun S; Yolcu E; Sahin C; Bilenoglu O; Isbilen M; Yildiz E
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.
    Francisco RDS; Benites LF; Lamarca AP; de Almeida LGP; Hansen AW; Gularte JS; Demoliner M; Gerber AL; de C Guimarães AP; Antunes AKE; Heldt FH; Mallmann L; Hermann B; Ziulkoski AL; Goes V; Schallenberger K; Fillipi M; Pereira F; Weber MN; de Almeida PR; Fleck JD; Vasconcelos ATR; Spilki FR
    Virus Res; 2021 Apr; 296():198345. PubMed ID: 33631222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil.
    Tort LFL; Ribeiro IP; Menezes LSR; Dos Santos AAC; Santos MP; Damasceno L; Silva PCR; de Siqueira MAMT; Brasil P; Bonaldo MC
    Mem Inst Oswaldo Cruz; 2021; 116():e210166. PubMed ID: 34755818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence.
    Naveca FG; Nascimento V; de Souza VC; Corado AL; Nascimento F; Silva G; Costa Á; Duarte D; Pessoa K; Mejía M; Brandão MJ; Jesus M; Gonçalves L; da Costa CF; Sampaio V; Barros D; Silva M; Mattos T; Pontes G; Abdalla L; Santos JH; Arantes I; Dezordi FZ; Siqueira MM; Wallau GL; Resende PC; Delatorre E; Gräf T; Bello G
    Nat Med; 2021 Jul; 27(7):1230-1238. PubMed ID: 34035535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York.
    Lesho E; Corey B; Lebreton F; Ong AC; Swierczewski BE; Bennett JW; Walsh EE; McGann P
    Clin Infect Dis; 2022 Mar; 74(5):909-912. PubMed ID: 34086878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.
    Ferrareze PAG; Franceschi VB; Mayer AM; Caldana GD; Zimerman RA; Thompson CE
    Infect Genet Evol; 2021 Sep; 93():104941. PubMed ID: 34044192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact.
    Vega-Magaña N; Sánchez-Sánchez R; Hernández-Bello J; Venancio-Landeros AA; Peña-Rodríguez M; Vega-Zepeda RA; Galindo-Ornelas B; Díaz-Sánchez M; García-Chagollán M; Macedo-Ojeda G; García-González OP; Muñoz-Valle JF
    Front Cell Infect Microbiol; 2021; 11():672562. PubMed ID: 34123874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Rate of Mutational Events in SARS-CoV-2 Genomes across Brazilian Geographical Regions, February 2020 to June 2021.
    de Souza UJB; Dos Santos RN; Campos FS; Lourenço KL; da Fonseca FG; Spilki FR; Corona-Ômica Br/McTi Network
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.
    Arantes I; Gomes Naveca F; Gräf T; ; Miyajima F; Faoro H; Luz Wallau G; Delatorre E; Reis Appolinario L; Cavalcante Pereira E; Venas TMM; Sampaio Rocha A; Serrano Lopes R; Mendonça Siqueira M; Bello G; Cristina Resende P
    Microbiol Spectr; 2022 Oct; 10(5):e0264121. PubMed ID: 36000897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study.
    Zhao S; Ran J; Han L
    Am J Trop Med Hyg; 2021 Sep; 105(5):1247-1254. PubMed ID: 34583340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage.
    Álvarez-Díaz DA; Laiton-Donato K; Torres-García OA; Ruiz-Moreno HA; Franco-Muñoz C; Beltran MA; Mercado-Reyes M; Rueda MG; Muñoz AL
    Virus Res; 2022 Jan; 308():198629. PubMed ID: 34780883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.